PharmaMar, S.A.

Drug Name	Phase	Indication	Designations	Patent
ASF1057	Phase 3	Seborrheic Dermatitis	-	-
AJM300	Phase 3	Colitis, Ulcerative	-	-
ASKB589	Phase 3	Gastroesophageal Junction Adenocarcinoma	-	-
YM060	Phase 3	Diarrhea-predominant Irritable Bowel Syndrome	-	-
SM-13496 (lurasidone HCl)	Phase 3	Schizophrenia	-	-
Ingenol mebutate gel, 0.015%	Phase 3	Actinic Keratosis	-	-
Remimazolam	Phase 3	Pediatric ALL	-	-
micafungin	Phase 3	Mycoses	-	-
LY03005 extended-release tablet	Phase 3	Major Depressive Disorder (MDD)	-	-
Amisulpride Injection	Phase 3	Nausea and Vomiting, Postoperative	-	-
Cocaine Hydrochloride Nasal Solution	Phase 3	ENT Disorder	-	-
ipragliflozin	Phase 3	Type 2 Diabetes Mellitus	-	-
Teneligliptin	Phase 3	Type 2 Diabetes Mellitus	-	-
ART-123	Phase 3	Severe Sepsis	-	-
Inersan	Phase 3	Chronic Periodontitis	-	-
MP-214 3mg	Phase 3	Schizophrenia	-	-
Mesalazine - TID 1000 mg	Phase 3	Active Ulcerative Colitis	-	-
olmesartan medoxomil	Phase 3	Essential Hypertension	-	-
Arformoterol tartrate inhalation solution	Phase 3	COPD	-	-
Lacosamide	Phase 3	Painful Diabetic Neuropathy	-	-
Calcipotriol plus hydrocortisone (LEO 80190)	Phase 3	Psoriasis Vulgaris	-	-
Azelaic acid foam, 15% (BAY39-6251)	Phase 3	Papulopustular Rosacea	-	-
LEO 80190 Vehicle	Phase 3	Psoriasis Vulgaris	-	-
Cebranopadol 400 ug	Phase 3	Acute Pain	-	-
Ensifentrine	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
ICP-248	Phase 3	Hematologic Malignancies	-	-
CDP870	Phase 3	Rheumatoid Arthritis	-	-
TA-650	Phase 3	Crohn's Disease	-	-
Lurasidone 20, 40, 60, 80 mg, flexibly dosed	Phase 3	Schizophrenia	-	-
IB1001	Phase 3	Hemophilia B	-	-
budesonide	Phase 3	Crohn´s Disease	-	-
Pre-screening Phase	Phase 3	Soil-Transmitted Helminths	-	-
Brivaracetam	Phase 3	Epilepsy	-	-
DPT-IPV-Hib-High（Combined Vaccine）	Phase 3	Immunization; Infection	-	-
M207 Microneedle System	Phase 3	Migraine	-	-
Ciclesonide nasal aerosol 37 mcg	Phase 3	Perennial Allergic Rhinitis	-	-
DPT-IPV-Hib (Combined Vaccine)	Phase 3	Immunization	-	-
norUrsodeoxycholic Acid	Phase 3	Primary Sclerosing Cholangitis	-	-
dasiglucagon	Phase 3	Congenital Hyperinsulinism	-	-
Lurasidone 40 mg	Phase 3	Schizophrenia	-	-
Lenalidomide	Phase 3	Relapsed/Refractory Marginal Zone Lymphoma	-	-
ASP7374	Phase 3	Influenza	-	-
PerioChip ®	Phase 3	Generalized Adult Periodontitis	-	-
Levonorgestrel	Phase 3	Contraception	-	-
Phlogenzym	Phase 3	Thrombophlebitis Leg	-	-
YM178	Phase 3	Urinary Bladder, Overactive	-	-
Thioctic Acid	Phase 3	Diabetic Polyneuropathy	-	-
Caspofungin	Phase 3	Candidiasis	-	-
INZ-701	Phase 3	Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency	-	-
Use Phase (Ulipristal Acetate, 30 mg)	Phase 3	Emergency Contraception	-	-
Oxycodone HCl controlled-release tablets	Phase 3	Pain	-	-
Control Arm (Conventional Therapy)	Phase 3	Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency	-	-
co-administration of cefepime and nacubactam	Phase 3	Complicated Urinary Tract Infection	-	-
Oxybutynin	Phase 3	Urge Urinary Incontinence	-	-
C21	Phase 3	Idiopathic Pulmonary Fibrosis	-	-
MCI-9042	Phase 3	Cerebral Infarction	-	-
Teneli / Teneli + SU	Phase 3	Type 2 Diabetes Mellitus	-	-
Broncho-Vaxom	Phase 3	Atopic Dermatitis	-	-
CDB-2914	Phase 3	Emergency Contraception	-	-
Dasotraline	Phase 3	Adult Attention Deficit Hyperactivity Disorder	-	-
Metronidazole	Phase 3	Haemorrhoidectomy	-	-
SPM 962	Phase 3	Parkinson Disease, Idiopathic	-	-
Nifedipine	Phase 3	Chronic Anal Fissure	-	-
LPRI424 (dienogest/ethinylestradiol)	Phase 3	Contraception	-	-
Ferinject (ferric carboxymaltose)	Phase 3	Iron Deficiency	-	-
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)	Phase 3	Coronary Artery Disease	-	-
Calcipotriol plus betamethasone dipropionate (LEO80185 gel)	Phase 3	Psoriasis of Scalp	-	-
MOB015B	Phase 3	Distal Subungual Onychomycosis	-	-
Salmeterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Qutenza (capsaicin) 8% topical system	Phase 3	Post Surgical Neuropathic Pain	-	-
Benzocaine Otic Solution	Phase 3	Pain	-	-
Levalbuterol tartrate HFA MDI	Phase 3	Exercise-induced Bronchospasm	-	-
Ciclesonide HFA Nasal Aerosol 320 mcg	Phase 3	Perennial Allergic Rhinitis	-	-
Tacrolimus	Phase 3	IgA Nephropathy	-	-
olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets	Phase 3	Essential Hypertension	-	-
VCT220	Phase 3	Obesity	-	-
AJG555	Phase 3	Chronic Constipation	-	-
Lubiprostone 24	Phase 3	Opioid-Induced Bowel Dysfunction	-	-
Orelabrutinib	Phase 3	Mantle Cell Lymphoma	-	-
Sevelamer carbonate	Phase 3	Chronic Kidney Disease Requiring Chronic Dialysis	-	-
K40a	Phase 3	Seborrhoeic Dermatitis of the Scalp	-	-
S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)	Phase 3	Pain	-	-
MP-214	Phase 3	Schizophrenia	-	-
ICP-332 Tablets	Phase 3	Chronic Spontaneous Urticaria (CSU)	-	-
MP-513	Phase 3	Type 2 Diabetes Mellitus	-	-
Relugolix Combination Therapy	Phase 3	Contraception	-	-
Ciclesonide HFA 160 μg	Phase 3	Seasonal Allergic Rhinitis	-	-
Tehalose 30gr	Phase 3	Muscular Dystrophy, Oculopharyngeal (OPMD)	-	-
ZuraPrep with 70% IPA	Phase 3	Surgical Site Infection	-	-
TDS-943 (topical diclofenac sodium 4% spray)	Phase 3	Osteoarthritis	-	-
alefacept	Phase 3	Chronic Plaque Psoriasis	-	-
Elacytarabine	Phase 3	Acute Myeloid Leukemia (AML)	-	-
calcipotriol and betamethasone (LEO 80185 gel)	Phase 3	Psoriasis Vulgaris	-	-
APVO101	Phase 3	Hemophilia B	-	-
dasotraline 4mg	Phase 3	Binge Eating Disorder	-	-
Lurasidone	Phase 3	Schizophrenia	-	-
TRS01	Phase 3	Non-infectious Anterior Uveitis	-	-
almorexant	Phase 3	Primary Insomnia	-	-
Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT	Phase 3	Allergic Rhinitis	-	-
Lurbinectedin	Phase 3	Leiomyosarcoma	-	-
Levetiracetam	Phase 3	Epilepsy	-	-
Ecraprost in lipid emulsion	Phase 3	Peripheral Vascular Disease	-	-
Relugolix Combination Tablet	Phase 3	Uterine Fibroids	-	-
SC1011	Phase 3	Idiopathic Pulmonary Fibrosis	-	-
Epratuzumab	Phase 3	Systemic Lupus Erythematosus	-	-
Sotatercept	Phase 3	Pulmonary Arterial Hypertension	-	-
Lubiprostone	Phase 3	Constipation - Functional	-	-
SOF	Phase 3	Chronic HCV Infection	-	-
YY-162	Phase 3	Mental Disorders	-	-
Eslicarbazepine acetate	Phase 3	Epilepsy	-	-
tacrolimus ointment	Phase 3	Dermatitis, Atopic	-	-
ciclesonide hydrofluoroalkane (HFA) nasal aerosol	Phase 3	Perennial Allergic Rhinitis	-	-
Lurbinectedin (PM01183)	Phase 3	Small-cell Lung Cancer	-	-
peficitinib	Phase 3	Arthritis, Rheumatoid	-	-
FK949E	Phase 3	Bipolar Depression	-	-
Topotecan	Phase 3	Relapsed Small Cell Lung Cancer	-	-
SPM 927	Phase 3	Diabetic Neuropathy	-	-
MCI-186	Phase 3	Amyotrophic Lateral Sclerosis (ALS)	-	-
BPI-7711	Phase 3	NSCLC	-	-
ICP-488 Tablets	Phase 3	Cutaneous Lupus Erythematosus (CLE)	-	-
Pegylated liposomal doxorubicin (PLD)	Phase 3	Ovarian Cancer	-	-
Irinotecan	Phase 3	Advanced Solid Tumors	-	-
Relugolix	Phase 3	Prostate Cancer	-	-
ferrous sulphate	Phase 3	Anaemia	-	-
Quetiapine XR	Phase 3	Schizophrenia	-	-
Eszopiclone	Phase 3	Insomnia	-	-
UGN-102	Phase 3	Bladder Cancer	-	-
acalabrutinib	Phase 3	Non Hodgkin Lymphoma	-	-
Botulinum Toxin A	Phase 3	Glabellar Frown Lines	-	-
Clifutinib	Phase 3	Leukemia, Acute Myeloid (AML)	-	-
Venetoclax	Phase 3	Chronic Lymphocytic Leukemia	-	-
Plitidepsin	Phase 3	Relapsed/Refractory Multiple Myeloma	-	-
Ropivacaine	Phase 3	Pain, Postoperative	-	-
Rotigotine	Phase 3	Idiopathic Parkinson's Disease	-	-
HEC74647PA+HEC110114	Phase 3	Chronic HCV Infection	-	-
AST-120	Phase 3	Chronic Kidney Disease	-	-
Teneli / Teneli + pio	Phase 3	Type 2 Diabetes Mellitus	-	-
VSL#3	Phase 3	Hepatic Encephalopathy	-	-
Obicetrapib	Phase 3	Atherosclerotic Cardiovascular Disease	-	-
Ingenol mebutate gel 0.05 %	Phase 3	Actinic Keratosis	-	-
Insulin Degludec and Insulin Aspart	Phase 3	Diabetes	-	-
Fezolinetant	Phase 3	Hot Flashes	-	-
Levocetirizine dihydrochloride	Phase 3	Rhinitis	-	-
Hydroquinone	Phase 3	Facial Melasma	-	-
Eicosapentaenoic Acid (EPA)	Phase 3	Adenomatous Polyps	-	-
Probiotic Arm	Phase 3	Mild and Moderate Chronic Periodontitis	-	-
Ciprodex®	Phase 3	Acute Otitis Externa	-	-
MP-424	Phase 3	Chronic Hepatitis C (CHC)	-	-
Mirabegron	Phase 3	Urinary Bladder, Overactive	-	-
Levocetirizine	Phase 3	Dermatitis, Atopic	-	-
LY01005 3.6 mg	Phase 3	Prostate Cancer	-	-
0.75% Phentolamine Ophthalmic Solution	Phase 3	Vision Loss Night	-	-
Tralokinumab	Phase 3	Atopic Dermatitis	-	-
Tideglusib	Phase 3	Congenital Myotonic Dystrophy	-	-
solifenacin succinate	Phase 3	Lower Urinary Tract Symptoms	-	-
Brivaracetam 25 mg	Phase 3	Unverricht-Lundborg Disease	-	-
Imiquimod	Phase 3	Carcinoma, Basal Cell	-	-
LEO 90100	Phase 3	Stable Plaque Psoriasis	-	-
FCM (Ferric carboxymaltose) high ferritin target	Phase 3	Iron Deficiency Anaemia	-	-
Calcipotriol plus betamethasone dipropionate gel (LEO 80185)	Phase 3	Psoriasis of Scalp	-	-
DFD06-Cream	Phase 3	Chronic Stable Plaque Psoriasis	-	-
Ingenol metabute	Phase 3	Actinic Keratosis	-	-
gilteritinib	Phase 3	Acute Myeloid Leukemia (AML)	-	-
Viltolarsen	Phase 3	Duchenne Muscular Dystrophy	-	-
Lurasidone 20 mg daily	Phase 3	Autism	-	-
Ibuprofen 600 mg Extended-Release Tablets	Phase 3	Pain	-	-
eszopiclone 3 mg	Phase 3	Primary Insomnia	-	-
LEO 43204 gel	Phase 3	Actinic Keratosis	-	-
Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg	Phase 3	Generalized Anxiety Disorder	-	-
Buprenorphine transdermal system	Phase 3	Pain	-	-
Buprenorphine transdermal patch	Phase 3	Osteoarthritis	-	-
LEO 90105 = calcipotriol + betamethasone dipropionate	Phase 3	Psoriasis	-	-
Lerotinib	Phase 3	Esophageal Cancer	-	-
Levalbuterol HFA MDI with top mounted actuation indicator	Phase 3	Asthma	-	-
PA21 (2.5 g tablet containing 500 mg iron)	Phase 3	Chronic Kidney Disease Requiring Chronic Dialysis	-	-
glepaglutide	Phase 3	Short Bowel Syndrome	-	-
Certolizumab pegol	Phase 3	Crohn's Disease	-	-
Roxadustat	Phase 3	Chronic Kidney Disease	-	-
PRC-063 oral capsules	Phase 3	ADHD	-	-
Levalbuterol 1.25 mg	Phase 3	Asthma	-	-
Eicosapentanoic Acid (EPA)	Phase 3	Familial Adenomatous Polyposis Coli	-	-
MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®)	Phase 3	Chronic Kidney Disease	-	-
ciclesonide	Phase 3	Perennial Allergic Rhinitis	-	-
Levalbuterol HCl	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Lurasidone HCl	Phase 3	Schizophrenia	-	-
AMPH ER Tab 5, 10, 15 and 20 mg	Phase 3	ADHD	-	-
Vernakalant Injection 20 mg/mL	Phase 3	Atrial Fibrillation	-	-
YM150	Phase 3	Atrial Fibrillation	-	-
tolterodine	Phase 3	Urinary Bladder, Overactive	-	-
2mg of ASC41	Phase 2	Non-alcoholic Fatty Liver Disease	-	-
ONO-2333Ms Experimental 2	Phase 2	Major Depressive Disorder	-	-
low dose budesonide tablet	Phase 2	Eosinophilic Esophagitis	-	-
DMTS	Phase 2	Pain, Postoperative	-	-
BGP-014	Phase 2	Ulcerative Colitis	-	-
Flurbiprofen	Phase 2	Periodontitis	-	-
LEO 80185 gel	Phase 2	Psoriasis Vulgaris	-	-
LEO 29102	Phase 2	Atopic Dermatitis	-	-
Rifamycin SV-MMX® 400 mg b.i.d.	Phase 2	Uncomplicated Diverticulitis	-	-
CM355	Phase 2	Hematoma	-	-
LPM3770164 sustained release tablet 5 mg	Phase 2	Tardive Dyskinesia (TD)	-	-
ONO-1101	Phase 2	Postoperative Supraventricular Tachyarrythmia	-	-
SEP-225289	Phase 2	Adult Attention Deficit Hyperactivity Disorder	-	-
PHP-201 0.25% ophthalmic solution	Phase 2	Normal Tension Glaucoma	-	-
CP-4055	Phase 2	Malignant Melanoma	-	-
LAT8881	Phase 2	Acute Migraine	-	-
E6011	Phase 2	Crohn's Disease	-	-
Naloxone SR 5 mg capsules	Phase 2	Chronic Pain	-	-
LEO 138559	Phase 2	Atopic Dermatitis	-	-
V120083	Phase 2	Osteo Arthritis Knee	-	-
TSX-002	Phase 2	Hypogonadism	-	-
OC-01 (varenicline) nasal spray	Phase 2	Dry Eye Disease	-	-
VNX001	Phase 2	Interstitial Cystitis	-	-
NS-065/NCNP-01	Phase 2	Duchenne Muscular Dystrophy	-	-
JTT-851	Phase 2	Type 2 Diabetes Mellitus	-	-
ICP-192	Phase 2	Intrahepatic Cholangiocarcinoma (ICC)	-	-
PD solution containing glucose	Phase 2	End Stage Renal Disease	-	-
HEC169096	Phase 2	Advanced Solid Tumor	-	-
LEO 43204	Phase 2	Actinic Keratosis	-	-
LEO 29102 cream	Phase 2	Psoriasis Vulgaris	-	-
APHD-012	Phase 2	Obese With Comorbidities	-	-
Alintegimod	Phase 2	Advanced Cancer	-	-
BBI608	Phase 2	Malignant Pleural Mesothelioma	-	-
PA101	Phase 2	Refractory Chronic Cough	-	-
LP0113 aerosol spray	Phase 2	Skin and Connective Tissue Diseases	-	-
NS-229	Phase 2	Eosinophilic Granulomatosis With Polyangiitis	-	-
OBI-902	Phase 2	Advanced Solid Tumor	-	-
X0002 Spray	Phase 2	KNEE OSTEOARTHRITIS	-	-
Betamethasone plus calcipotriol	Phase 2	Psoriasis Vulgaris	-	-
Tacrolimus Ointment 0.1%	Phase 2	Dermatitis, Atopic	-	-
Heated lidocaine/tetracaine patch	Phase 2	Myofascial Pain Syndromes	-	-
Paclitaxel	Phase 2	Cancer	-	-
VentaProst (inhaled epoprostenol delivered via a dedicated delivery system)	Phase 2	COVID-19	-	-
NT-KO-003	Phase 2	Relapsing Remitting Multiple Sclerosis	-	-
XEN-D0501	Phase 2	Efficacy	-	-
ACP-196	Phase 2	Metastatic Pancreatic Cancer	-	-
PRI-724	Phase 2	Acute Myeloid Leukemia	-	-
ingenol mebutate	Phase 2	Actinic Keratosis	-	-
JTT-302	Phase 2	Dyslipidemia	-	-
Levosimendan	Phase 2	Transient Ischemic Attack	-	-
Formatris 24µg	Phase 2	Asthma	-	-
Patiromer	Phase 2	Hyperkalemia	-	-
ON 01910.Na	Phase 2	Myelodysplastic Syndrome	-	-
ODM-201	Phase 2	Prostate Cancer	-	-
CyCol™	Phase 2	Mild to Moderate Ulcerative Colitis	-	-
HEC585	Phase 2	Idiopathic Pulmonary Fibrosis	-	-
Phentolamine Mesylate Ophthalmic Solution 1%	Phase 2	Mydriasis	-	-
Sepranolone (UC1010) low dose	Phase 2	Premenstrual Dysphoric Disorder	-	-
ZED1227	Phase 2	NAFLD	-	-
Temozolomide	Phase 2	Glioblastoma	-	-
QHRD106 Injection (Low-dose group)	Phase 2	Acute Ischemic Stroke	-	-
NS-018	Phase 2	Primary Myelofibrosis	-	-
Pudexacianinium chloride	Phase 2	Laparoscopic/Minimally Invasive Colorectal Surgery	-	-
SKB264	Phase 2	Non-small Cell Lung Cancer	-	-
STP938	Phase 2	Lymphoma, B-Cell	-	-
Olaptesed pegol - Monotherapy	Phase 2	Metastatic Colorectal Cancer	-	-
DAG181	Phase 2	Chronic HCV Infection	-	-
JTE-051	Phase 2	Rheumatoid Arthritis	-	-
recAP	Phase 2	Acute Kidney Injury	-	-
OSI-211 (Liposomal Lurtotecan)	Phase 2	Ovarian Neoplasms	-	-
Udenafil	Phase 2	Single Ventricle Heart Disease After Fontan Surgery	-	-
Cultured Thymus Tissue Implantation (CTTI)	Phase 2	DiGeorge Anomaly	-	-
12 cm2 - 2 Active DMTS Patches	Phase 2	Agitation	-	-
Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR)	Phase 2	Hematologic Diseases	-	-
MKP10241	Phase 2	Type 2 Diabetes Mellitus (T2DM)	-	-
JM-010 group A	Phase 2	Dyskinesias	-	-
MT-7117	Phase 2	Diffuse Cutaneous Systemic Sclerosis	-	-
ICP-322	Phase 2	Prurigo Nodularis (PN)	-	-
SMP3124LP	Phase 2	Solid Tumor	-	-
GS-248	Phase 2	Systemic Sclerosis	-	-
Delgocitinib cream	Phase 2	Chronic Hand Eczema	-	-
LP-003 Dose 1 (Single)	Phase 2	Allergic Diseases	-	-
SPRC-AB01	Phase 2	Chronic Sinusitis	-	-
LEO 90105	Phase 2	Psoriasis Vulgaris	-	-
unoprostone isopropyl	Phase 2	Dry Age-related Macular Degeneration	-	-
ACP-319	Phase 2	Non-Hodgkins Lymphoma	-	-
LUT014 Gel	Phase 2	Radiation Dermatitis	-	-
N17350	Phase 2	Neoplasms, Solid Tumor	-	-
LEO 124249 ointment 30 mg/g	Phase 2	Inverse Psoriasis	-	-
MT-3995 Low	Phase 2	Diabetic Nephropathy	-	-
Enzalutamide	Phase 2	Advanced Hepatocellular Carcinoma	-	-
lidocaine and tetracaine cream 7%/7%	Phase 2	Postherpetic Neuralgia	-	-
AP1189, 60 mg	Phase 2	Rheumatoid Arthritis	-	-
Ecopipam	Phase 2	Tourette's Syndrome	-	-
TRS01 eye drops	Phase 2	Non-infectious Anterior Uveitis	-	-
Esketamine DPI - low dose	Phase 2	Major Depressive Disorder	-	-
Brimonidine tartrate Gel	Phase 2	EGFR Inhibitor-associated Rash	-	-
PL2200	Phase 2	Gastroduodenal Ulceration	-	-
Vonafexor	Phase 2	Non-alcoholic Steatohepatitis	-	-
AP1189, 40 mg	Phase 2	Rheumatoid Arthritis (RA)	-	-
SPP635	Phase 2	Hypertension	-	-
RPh201, botanical drug product	Phase 2	Healthy Volunteers	-	-
IZN-6D4 Gel	Phase 2	Diabetic Foot Ulcer	-	-
CVXL-0107	Phase 2	Idiopathic Parkinson Disease	-	-
MT-3995	Phase 2	NASH	-	-
AC102 gel	Phase 2	Hearing Loss, Sensorineural	-	-
Ondansetron	Phase 2	CINV	-	-
ASKG915	Phase 2	Advanced Solid Tumors	-	-
NanoLithium® NP03	Phase 2	Alzheimer's Disease	-	-
Botulinum toxin A "BoNT/A-DP"	Phase 2	Frown Lines	-	-
Delgocitinib cream vehicle	Phase 2	Frontal Fibrosing Alopecia	-	-
Naronapride	Phase 2	Gastroparesis	-	-
rigosertib	Phase 2	Myelodysplastic Syndrome	-	-
100 mg AP1189	Phase 2	Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy	-	-
PP-001	Phase 2	Non-infectious Uveitis	-	-
ONO-6950	Phase 2	Asthma	-	-
EP0042	Phase 2	Acute Myeloid Leukemia	-	-
Cebranopadol 100 µg	Phase 2	Chronic Pain	-	-
BPI-7711 Capsule	Phase 2	Non-small Cell Lung Cancer	-	-
Oxymetazoline gel	Phase 2	Fecal Incontinence	-	-
ART0380	Phase 2	Advanced Cancer	-	-
enoxaparin	Phase 2	Thromboembolism	-	-
Daivobet® gel applied then removed after 10 minutes (+/- 2 minutes)	Phase 2	Psoriasis Vulgaris	-	-
LEO43204	Phase 2	Acne Vulgaris	-	-
decitabine in combination with genistein	Phase 2	Non Small Cell Lung Cancer	-	-
HEC96719	Phase 2	Non-Alcoholic Steatohepatitis	-	-
Pactimibe	Phase 2	Atherosclerosis	-	-
Mycograb, Docetaxel	Phase 2	Cancer of the Breast	-	-
LY01021	Phase 2	Assisted Reproduction	-	-
avacincaptad pegol	Phase 2	Stargardt's Macular Dystrophy	-	-
L-carnitine	Phase 2	End-Stage Renal Disease	-	-
HL-085	Phase 2	Melanoma	-	-
ASP8825	Phase 2	Restless Legs Syndrome	-	-
Esketamine DPI - medium dose	Phase 2	Bipolar Depression	-	-
MT-3995 High	Phase 2	Diabetic Nephropathy	-	-
XEN-D0501, 1 mg/tablet	Phase 2	Diabetes Mellitus, Type 2	-	-
JTT-705 600 mg and simvastatin 40 mg	Phase 2	Dyslipidemia	-	-
PA101B	Phase 2	Uremic Pruritus	-	-
SP-02L (darinaparsin for injection)	Phase 2	Peripheral T-Cell Lymphoma	-	-
Aprepitant	Phase 2	Pruritus	-	-
ASF 1096 0.5 % cream	Phase 2	Discoid Lupus Erythematosus	-	-
ASP3291	Phase 2	Ulcerative Colitis	-	-
GM102	Phase 2	Colorectal Cancer	-	-
Covidir injections	Phase 2	COVID-19	-	-
Diacerein	Phase 2	Complications of Diabetes Mellitus	-	-
X842	Phase 2	Erosive Esophagitis	-	-
SPC2996	Phase 2	Chronic Lymphocytic Leukemia	-	-
ASP8232	Phase 2	Healthy Subjects	-	-
Pradigastat Tablets 20mg	Phase 2	Functional Constipation	-	-
EP0057	Phase 2	Ovarian Cancer	-	-
JTT-705 600 mg and atorvastatin 20 mg	Phase 2	Dyslipidemia	-	-
Alkaline Phosphatase	Phase 2	Sepsis	-	-
Azelaic acid	Phase 2	Papulopustular Rosacea	-	-
SEP-4199 200 mg	Phase 2	Depressive Episode	-	-
Rifalazil 25 milligram	Phase 2	Chlamydia Trachomatis Infection	-	-
YM155	Phase 2	Melanoma	-	-
ICP-022	Phase 2	Waldenstrom's Macroglobulinemia Recurrent	-	-
OSI-906	Phase 2	Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy	-	-
Luspatercept	Phase 2	Myelodysplastic Syndromes	-	-
ProTrans	Phase 2	Type1diabetes	-	-
ASP3652	Phase 2	Cystitis, Interstitial	-	-
Naproxen	Phase 2	Healthy Volunteers	-	-
5% VDA-1102	Phase 2	Actinic Keratosis	-	-
MT-3995 Middle	Phase 2	Diabetic Nephropathy	-	-
Imiquimod 5 % Cream	Phase 2	Actinic Keratosis	-	-
Vipoglanstat	Phase 2	Endometriosis	-	-
Depigoid Phleum	Phase 2	Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma	-	-
ODM-212	Phase 2	Solid Tumours	-	-
PM01183	Phase 2	Breast Cancer	-	-
Zalypsis	Phase 2	Ewing's Sarcoma	-	-
VX-745	Phase 2	Alzheimer's Disease	-	-
APD515	Phase 2	Xerostomia in Advanced Cancer Patients	-	-
Aplidin®	Phase 2	Leukemia	-	-
Calcipotriol plus betamethasone dipropionate (LEO 80185) gel	Phase 2	Psoriasis Vulgaris	-	-
APLIDIN (plitidepsin)	Phase 2	Myelofibrosis	-	-
Plitidepsin 1.5 mg / day	Phase 2	COVID-19 Infection	-	-
Transdermal Ketoprofen Patch with CHADD	Phase 2	Pain	-	-
TL-925	Phase 2	Allergic Conjunctivitis	-	-
Docetaxel	Phase 2	Non-Small Cell Lung Cancer (NSCLC)	-	-
PM54	Phase 2	Advanced Malignancies	-	-
EXE-346	Phase 2	Ileal Pouch	-	-
Montelukast	Phase 2	Asthma	-	-
PM060184	Phase 2	Advanced Colorectal Cancer	-	-
Flurbiprofen Tape (Arm 2)	Phase 2	Chronic Low Back Pain	-	-
IV CP-4126	Phase 2	Advanced Adenocarcinoma of Pancreas	-	-
BPI-1178	Phase 2	Advanced Solid Tumor	-	-
DFD06 Cream	Phase 2	Psoriasis	-	-
APD421	Phase 2	Postoperative Nausea and Vomiting	-	-
GRASPA	Phase 2	Acute Lymphoblastic Leukemia	-	-
VIOKASE 16	Phase 2	Exocrine Pancreatic Insufficiency	-	-
OCZ103-OS	Phase 2	Non-small Cell Lung Cancer	-	-
CP-461	Phase 2	Prostate Cancer	-	-
GA Depot 80 mg	Phase 2	Multiple Sclerosis	-	-
Fosmidomycin and Clindamycin co-administration	Phase 2	Malaria	-	-
Phenyephrine	Phase 2	Incontinence	-	-
pentamidine	Phase 2	Colorectal Cancer	-	-
Calcipotriol and LEO80122 (LEO19123 cream)	Phase 2	Hand Eczema	-	-
ONO-5129	Phase 2	Diabetes Mellitus, Type 2	-	-
TOP-N53	Phase 2	Digital Ulcers in Systemic Sclerosis	-	-
RPL554	Phase 2	Asthma	-	-
Tafasitamab and Lenalidomide	Phase 2	DLBCL	-	-

Generalized Adult Periodontitis

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move

Regulatory Approvals

Frequently asked questions

What is in PharmaMar, S.A.'s drug pipeline?→

CatalystAlert tracks 390 drug candidates in PharmaMar, S.A.'s (PHM.MC) pipeline across Phase 3, Phase 2. Its lead program is ASF1057 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is PharmaMar, S.A.'s next FDA catalyst?→

PharmaMar, S.A.'s (PHM.MC) next tracked catalyst is a Phase 2 expected July 15, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track PHM.MC biotech catalysts?→

Add PHM.MC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PharmaMar, S.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

PharmaMar, S.A.

Market Overview

PHM.MC News

Catalyst Timeline

Pipeline & FDA Submissions

Competitive Positions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals

Frequently asked questions